연구성과로 돌아가기
2023 연구성과별 연구자 정보 (916 / 2675)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period | Chung, Wookyung | Chung, W | 3 | Gachon Univ, Dept Internal Med, Gil Med Ctr, Inchon, South Korea | hdutopia@gmail.com;imyongkim@gmail.com; | |||||
| Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period | Kim, Yong Lim | Kim, YL | 4 | Kyungpook Natl Univ Hosp, Dept Internal Med, Daegu, South Korea | AGK-3172-2022 | Kim, Yong-Lim | hdutopia@gmail.com;imyongkim@gmail.com; | |||
| Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period | Kim, Yaerim | Kim, Y | 5 | 교신저자 | Keimyung Univ, Dept Internal Med, Dongsan Hosp, Daegu, South Korea | T-8627-2019 | Kim, Nan | 0000-0003-1596-1528 | Kim, Yaerim | hdutopia@gmail.com;imyongkim@gmail.com; |
| Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period | Han, Seungyeup | Han, S | 6 | Keimyung Univ, Dept Internal Med, Dongsan Hosp, Daegu, South Korea | 0000-0002-7561-6534 | Han, Seungyeup | hdutopia@gmail.com;imyongkim@gmail.com; | |||
| Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period | Jung, Yeonsoon | Jung, Y | 7 | Kosin Univ, Dept Internal Med, Gospel Hosp, Busan, South Korea | hdutopia@gmail.com;imyongkim@gmail.com; | |||||
| Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period | Na, Ki Young | Na, KY | 8 | Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea | J-5456-2012 | Na, Ki | hdutopia@gmail.com;imyongkim@gmail.com; | |||
| Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period | Lee, Kyu Beck | Lee, KB | 9 | Kangbuk Samsung Hosp, Dept Internal Med, Seoul, South Korea | 0000-0002-3904-5404 | Lee, kyu-Beck | hdutopia@gmail.com;imyongkim@gmail.com; | |||
| Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period | Oh, Yun Kyu | Oh, YK | 10 | SMG SNU Boramae Med Ctr, Dept Internal Med, Seoul, South Korea | J-5542-2012 | Oh, Yun | hdutopia@gmail.com;imyongkim@gmail.com; | |||
| Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period | Park, Hyeong Cheon | Park, HC | 11 | Gangnam Severance Hosp, Dept Internal Med, Seoul, South Korea | hdutopia@gmail.com;imyongkim@gmail.com; | |||||
| Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period | Han, Seung Hyeok | Han, SH | 12 | Severance Hosp, Dept Internal Med, Seoul, South Korea | K-4559-2018 | Han, Seung | 0000-0001-7923-5635 | Han, Seung Hyeok | hdutopia@gmail.com;imyongkim@gmail.com; | |
| Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period | Yoo, Tae Hyun | Yoo, TH | 13 | Severance Hosp, Dept Internal Med, Seoul, South Korea | 0000-0002-9183-4507 | Yoo, Tae-Hyun | hdutopia@gmail.com;imyongkim@gmail.com; | |||
| Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period | Kim, Yeong Hoon | Kim, YH | 14 | Inje Univ, Dept Internal Med, Busan Paik Hosp, Busan, South Korea | hdutopia@gmail.com;imyongkim@gmail.com; | |||||
| Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period | Kim, Soo Wan | Kim, SW | 15 | Chonnam Natl Univ, Dept Internal Med, Med Sch, Gwangju, South Korea | ADR-9663-2022 | Kim, Soo-Yeon | hdutopia@gmail.com;imyongkim@gmail.com; | |||
| Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period | Lee, Kang Wook | Lee, KW | 16 | Chungnam Natl Univ Hosp, Dept Internal Med, Daejeon, South Korea | hdutopia@gmail.com;imyongkim@gmail.com; | |||||
| Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period | Park, Hayne Cho | Park, HC | 17 | Hallym Univ, Dept Internal Med, Kangnam Sacred Heart Hosp, Seoul, South Korea | hdutopia@gmail.com;imyongkim@gmail.com; |
페이지 이동: